Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Journal of Fungi (Basel, Switzerland)|September 28, 2021
Mucormycosis in CAPA, a Possible Fungal Super-InfectionPaola Saltini, Emanuele Palomba, Valeria Castelli, et al.Respiratory Research|October 23, 2023
Walking the path of treatable traits in interstitial lung diseasesFrancesco Amati, Paolo Spagnolo, Christopher J Ryerson, et al.International Journal of Molecular Sciences|January 21, 2022
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung DiseasesFrancesco Amati, Anna Stainer, Marco Mantero, et al.ERJ Open Research|March 30, 2022
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patientsStefano Aliberti, Francesco Amati, Andrea Gramegna, et al.Infection|September 25, 2025
Post-tuberculosis lung disease: a guide for cliniciansGiovanni Fumagalli, Jessica Mencarini, Irene Sini, et al.Internal and Emergency Medicine|August 15, 2022
Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational studyDeborah Blanca, Selene Nicolosi, Alessandra Bandera, et al.ERJ Open Research|November 5, 2025
Lung disease in never-smokers with severe α<sub>1</sub>-antitrypsin deficiency: the EARCO RegistryChiara Premuda, Cristina Aljama, Galo Granados, et al.Frontiers in Medicine|April 8, 2022
Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up StudyAgnese Comelli, Giulia Viero, Greta Bettini, et al.Respiratory Research|October 10, 2020
COVID-19 multidisciplinary high dependency unit: the Milan modelStefano Aliberti, Francesco Amati, Maria Pappalettera, et al.Journal of Infection and Public Health|January 23, 2024
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern ItalyAndrea Lombardi, Simone Villa, Marta Colaneri, et al.Pageof 6